$1.16
0.021.75%
In chiusura: -
$1.16
-0.00030-0.03%
After hour: Oct 31, 5:24 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Heron Therapeutics Inc (NASDAQ:HRTX) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 34.38M a 32.90M. Questo rappresenta il 22.21% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Heron Therapeutics Corp (XNAS:HRTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 1.39M azioni scambiate al giorno, ci vorrebbero 23.73 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
32.90M
Vendite allo scoperto %
22.2%
Giorni di copertura
23.73
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
HRTX | Heron Therapeutics, Inc. Commo | 10/15/2025 | 10/24/2025 | 22.21% | 148,096,484 | 32,896,288 | 1,386,553 | 23.73 | |
HRTX | Heron Therapeutics, Inc. Commo | 09/30/2025 | 10/09/2025 | 23.21% | 148,096,484 | 34,375,529 | 1,797,920 | 19.12 | |
HRTX | Heron Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 22.26% | 148,096,484 | 32,961,185 | 1,192,627 | 27.64 | |
HRTX | Heron Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 27.43% | 118,073,873 | 32,387,957 | 1,751,517 | 18.49 | |
HRTX | Heron Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 28.15% | 118,073,873 | 33,233,592 | 3,147,880 | 10.56 | |
HRTX | Heron Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 30.04% | 117,345,709 | 35,256,448 | 926,641 | 38.05 | |
HRTX | Heron Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 30.10% | 117,345,709 | 35,322,600 | 1,255,026 | 28.14 | |
HRTX | Heron Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 31.47% | 117,345,709 | 36,923,997 | 1,888,399 | 19.55 | |
HRTX | Heron Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 29.15% | 117,345,709 | 34,206,257 | 1,011,720 | 33.81 | |
HRTX | Heron Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 28.94% | 117,345,709 | 33,960,047 | 894,341 | 37.97 | |
HRTX | Heron Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 29.33% | 117,345,709 | 34,412,865 | 3,086,310 | 11.15 | |
HRTX | Heron Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 28.38% | 117,345,709 | 33,297,417 | 1,006,090 | 33.1 | |
HRTX | Heron Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | 28.00% | 117,732,600 | 32,964,019 | 1,281,203 | 25.73 | |
HRTX | Heron Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 27.62% | 117,732,600 | 32,518,881 | 1,322,354 | 24.59 | |
HRTX | Heron Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 27.24% | 117,732,600 | 32,069,271 | 2,233,635 | 14.36 | |
HRTX | Heron Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 26.61% | 117,732,600 | 31,326,110 | 3,199,462 | 9.79 | |
HRTX | Heron Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 26.14% | 117,732,600 | 30,769,600 | 967,865 | 31.79 | |
HRTX | Heron Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 26.19% | 117,732,600 | 30,838,973 | 1,461,306 | 21.1 | |
HRTX | Heron Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 26.38% | 117,732,600 | 31,057,581 | 1,435,732 | 21.63 | |
HRTX | Heron Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 26.09% | 117,732,600 | 30,711,761 | 1,894,867 | 16.21 | |
HRTX | Heron Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 25.47% | 117,732,600 | 29,984,772 | 10,431,924 | 2.87 | |
HRTX | Heron Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 23.40% | 117,732,600 | 27,544,540 | 1,460,084 | 18.87 | |
HRTX | Heron Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 23.71% | 117,732,600 | 27,910,496 | 2,385,992 | 11.7 | |
HRTX | Heron Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 24.56% | 117,305,705 | 28,810,535 | 1,422,532 | 20.25 | |
HRTX | Heron Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 26.12% | 117,305,705 | 30,643,570 | 1,385,272 | 22.12 | |
HRTX | Heron Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 27.03% | 117,305,705 | 31,703,092 | 2,437,827 | 13 | |
HRTX | Heron Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 30.21% | 117,305,705 | 35,441,558 | 1,662,485 | 21.32 | |
HRTX | Heron Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 30.62% | 117,305,705 | 35,918,079 | 1,387,603 | 25.88 | |
HRTX | Heron Therapeutics, Inc. Commo | 08/15/2024 | 08/26/2024 | 30.66% | 117,305,705 | 35,961,755 | 3,569,534 | 10.07 | |
HRTX | Heron Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 30.38% | 117,305,705 | 35,632,094 | 2,118,056 | 16.82 | |
HRTX | Heron Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 30.66% | 116,290,846 | 35,655,804 | 2,436,475 | 14.63 | |
HRTX | Heron Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 28.23% | 116,290,846 | 32,824,158 | 2,800,417 | 11.72 | |
HRTX | Heron Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 26.20% | 116,290,846 | 30,465,169 | 1,494,860 | 20.38 | |
HRTX | Heron Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 25.83% | 116,290,846 | 30,040,177 | 2,703,039 | 11.11 | |
HRTX | Heron Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 26.03% | 116,290,846 | 30,268,749 | 2,420,085 | 12.51 | |
HRTX | Heron Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 23.47% | 116,290,846 | 27,291,931 | 2,400,035 | 11.37 | |
HRTX | Heron Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 21.92% | 116,000,352 | 25,433,045 | 1,369,570 | 18.57 | |
HRTX | Heron Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 19.57% | 130,551,171 | 25,551,664 | 1,648,788 | 15.5 | |
HRTX | Heron Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 19.48% | 130,551,171 | 25,426,080 | 3,863,170 | 6.58 | |
HRTX | Heron Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 18.79% | 130,551,171 | 24,532,587 | 1,657,642 | 14.8 | |
HRTX | Heron Therapeutics, Inc. Commo | 02/15/2024 | 02/27/2024 | 18.89% | 130,295,226 | 24,615,510 | 2,166,470 | 11.36 | |
HRTX | Heron Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 18.67% | 130,295,226 | 24,326,240 | 4,431,675 | 5.49 | |
HRTX | Heron Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 16.52% | 130,295,226 | 21,521,576 | 4,007,310 | 5.37 | |
HRTX | Heron Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 15.51% | 130,295,226 | 20,213,686 | 2,018,232 | 10.02 | |
HRTX | Heron Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 16.12% | 130,295,226 | 21,003,440 | 2,789,415 | 7.53 | |
HRTX | Heron Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 16.56% | 130,295,226 | 21,583,381 | 4,543,232 | 4.75 | |
HRTX | Heron Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 13.50% | 130,295,226 | 17,593,531 | 4,125,001 | 4.27 | |
HRTX | Heron Therapeutics, Inc. Commo | 10/31/2023 | 11/09/2023 | 15.22% | 120,981,862 | 18,412,817 | 1,889,246 | 9.75 |
In cerca di azioni più vendute allo scoperto?